Free Trial

Demant A/S (OTCMKTS:WILYY) Shares Gap Up - Time to Buy?

Demant A/S logo with Medical background
Image from MarketBeat Media, LLC.

Key Points

  • Shares gapped up premarket from $13.45 to an open of $16.30 and last traded at $16.30 on light volume (419 shares).
  • Jefferies upgraded the stock from "hold" to "strong-buy"; overall there are two Strong Buy and one Hold ratings, giving an average rating of "Buy".
  • Demant is a Denmark-based hearing health care company (brands include Oticon, Bernafon and Sonic, plus Oticon Medical implants); its 50-day SMA is $14.17, 200-day SMA $16.15, and debt-to-equity is 1.65.
  • Interested in Demant A/S? Here are five stocks we like better.

Demant A/S Unsponsored ADR (OTCMKTS:WILYY - Get Free Report)'s stock price gapped up prior to trading on Tuesday . The stock had previously closed at $13.45, but opened at $16.30. Demant A/S shares last traded at $16.30, with a volume of 419 shares changing hands.

Analyst Upgrades and Downgrades

Separately, Jefferies Financial Group raised shares of Demant A/S from a "hold" rating to a "strong-buy" rating in a research report on Wednesday, March 18th. Two research analysts have rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of "Buy".

Read Our Latest Analysis on Demant A/S

Demant A/S Price Performance

The company has a debt-to-equity ratio of 1.65, a current ratio of 1.36 and a quick ratio of 1.00. The company's 50-day simple moving average is $14.17 and its 200-day simple moving average is $16.15.

Demant A/S Company Profile

(Get Free Report)

Demant A/S is a Denmark-based global hearing health care company specializing in the development, manufacture and distribution of hearing solutions and audiological diagnostic instruments. The company's flagship brands include Oticon, Bernafon and Sonic, which offer a range of hearing aids designed to address various levels of hearing loss. In addition to personal hearing devices, Demant provides diagnostic equipment such as audiometers and tympanometers, supporting hearing care professionals in accurate assessment and fitting of hearing solutions.

Beyond hearing aids and diagnostics, Demant's product portfolio extends to hearing implants—cochlear and bone-anchored systems—through its Oticon Medical division.

Further Reading

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Demant A/S Right Now?

Before you consider Demant A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Demant A/S wasn't on the list.

While Demant A/S currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply click the link below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines